Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma [Phase 3]
Phase 3 trial evaluating MEDI5752 in combination with carboplatin and pemetrexed for unresectable pleural mesothelioma is currently active b…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy [Phase 1, Phase 2]
Clinical trial evaluating oral 7HP349 (Alintegimod) in combination with ipilimumab, followed by nivolumab monotherapy, in patients with adva…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy [Phase 2]
A Phase 2 study is evaluating Ivonescimab for pleural mesothelioma that has progressed after prior immunotherapy and chemotherapy; the trial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma [Phase 2]
This clinical trial update describes a Phase 2 study testing the addition of immunotherapy before surgery for patients with pleural mesothel…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma [NA]
This clinical trial update notes a study evaluating partial pleurectomy (surgery) for unresectable pleural mesothelioma and indicates the st…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating Fianlimab with cemiplimab and chemotherapy, or cemiplimab with chemotherapy, in patients with pleural mesothelioma.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants [Phase 2]
Phase 2 trial comparing nivolumab plus ipilimumab versus pemetrexed with platinum for unresectable pleural mesothelioma in Chinese participa…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) [Phase 2]
CHIMERA is a Phase 2 trial evaluating induction chemotherapy plus immunotherapy in patients with resectable epithelioid and biphasic pleural…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]
Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) [Phase 2]
A Phase 2 study evaluating SAR444245 in combination with other anticancer therapies for pleural mesothelioma and non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Clinical trial status update indicates that Tumor Treating Fields (TTFields) are being studied in general routine clinical care for patients…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Study of Sacituzumab Govitecan in People With Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating Sacituzumab Govitecan for mesothelioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma [Phase 2]
This update describes a Phase 2 clinical trial assessing the diagnostic accuracy and clinical value of FAPI PET imaging in pleural mesotheli…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pembrolizumab in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating pembrolizumab in malignant mesothelioma and related subtypes; the study is active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
A pilot clinical trial investigating the role of gut flora in metastatic mesothelioma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma [Phase 1]
Phase 1 study of Galinpepimut-S in combination with nivolumab for pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: A Study of MT027 in Patients with Pleural Malignant Tumors [Phase 1]
Phase 1 clinical trial evaluating MT027 in patients with pleural malignant tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Evaluation of Response by FLT PET in Mesothelioma [NA]
This clinical trial evaluates FLT PET imaging to assess treatment response in patients with pleural mesothelioma and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma [Phase 2]
Phase 2 study evaluating cadonilimab in combination with chemotherapy for recurrent or refractory pleural mesothelioma; the trial is not yet…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: eRAPID: Online Symptom Reporting in Lung Cancer [NA]
The eRAPID online symptom reporting study in thoracic cancers has completed, including non-small cell lung cancer, small-cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial update evaluating nivolumab and ipilimumab with or without UV1 vaccination as second-line therapy for malignant mesothelioma.